Vilnius University: study centers: "Vilnius University Hospital " Santaros Clinic", "Vilniaus Gimdymo Namai"
Vilnius, Lithuania
Location status: Recruiting
NCT Number: NCT07426770
The main goal of this study to compare self-training postpartum and training with a specialist support (physiotherapist and physical medicine and rehabilitation doctor) effect on pelvic floor dysfunction prevention and treatment in postpartum period.
Hypothesis: The implementation of postpartum rehabilitation helps to alleviate existing symptoms of pelvic floor dysfunction and prevents pelvic floor dysfunction.
Study goals:
* To objectively evaluate changes in pelvic organ position and pelvic floor muscle function in postpartum period, before and after specialised rehabilitation program * To objectively evaluate pelvic floor symptoms and their influence on woman life quality * To compare data (changes in pelvic floor muscle coordination and strength, pelvic organ position and changes in life quality according to validated questionnaires)
Study participants will:
* Get an examination by obstetrician-gynaecologist, physical medicine and rehabilitation doctor and physiotherapist in 6 to 10 weeks postpartum period. * One group of participants will attend physiotherapy, biofeedback and electro stimulation procedures with a guidance of a specialist. * Other group of participants gets a recommendations and instructions of training and self-trains at home. To remind of training and help record training time "squeezy" app (an application designed for a mobile device) will be offered. * All groups of participants will be asked to fill life quality related questionnaires: (ICIQ-UI SF: International Consultation on Incontinence Questionnaire; P-QoL: Prolapse Quality-of-Life Questionnaire; PISQ-IR: Pelvic Organ Prolapse/ Urinary Incontinence Sexual Questionnaire IUGA revised; FSFI: female sexual function index; MOS-SF36 Medical Outcomes Study Short Form-36).
Interested in participating?
Request Info18 year–50 year
Female
Interventional
Not applicable
Vilnius, Lithuania
Location status: Recruiting
Objectives of the Biomedical Research:
Supervised training (specialist-led);
Self-training at home (based on specialist recommendations);
Comprehensive Description of Evaluated Outcomes Primary and Secondary Study Endpoints
Primary Endpoints: Changes indicating the effect of applied rehabilitation measures on the reduction and prevention of pelvic dysfunction symptoms:
Change in PFM contraction force and strength according to the Modified Oxford Scale.
Change in POP-Q scores.
St. Mark's Score for fecal incontinence: evaluating the change in score over the course of the study.
Pelvic and perineal ultrasound data: assessing symmetrical PFM contraction, changes in vaginal hiatus width, and urethral mobility. Comparison of results between study groups.
Persistence of PFD symptoms as reported by patients.
Changes in Quality of Life (QoL) and clinical outcome questionnaires: * ICIQ-UI SF (International Consultation on Incontinence Questionnaire Short Form); P-QoL (Prolapse Quality-of-Life Questionnaire); PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA revised); FSFI (Female Sexual Function Index); MOS-SF36 (Medical Outcomes Study Short Form-36).
Changes in musculoskeletal functions: * Objective assessment of PFM state via contraction force and Pressure Biofeedback activity evaluation.
Assessment of diastasis recti abdominis using palpation and ultrasound.
Pain assessment (abdominal, perineal, pelvic, pubic symphysis, and lumbosacral) using the Visual Analogue Scale (VAS).
Evaluation of gait, balance, and coordination.
Core stability and transversus abdominis activity (using a stabilizer); static endurance tests for abdominal and back muscles.
Secondary Endpoints: Factors potentially influencing the effectiveness of the rehabilitation program:
Demographics and History: Mean age, BMI, parity (number of pregnancies/deliveries), neonatal weight, and head circumference.
Obstetric Factors: Mode of delivery, delivery-related factors (induction, gestational age, fetal presentation, delivery method: natural, ventouse, c-section).
Pathologies: Pregnancy-related diseases (nausea/vomiting, intrahepatic cholestasis, preeclampsia, gestational diabetes), infectious/inflammatory diseases during pregnancy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Physiotherapy, Biofeedback training, electrostimulation
Other names: pelvic floor dysfunction app
Time frame: Asked at the beginning (first postpartum visit, 6-8 weeks postpartum), after first set of training (6months), after second set of training (12 months)
Self-reported improvement of symptoms (for example: pain, urinary incontinence, fecal incontinence, vaginal "laxity")
Time frame: Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning
Individual change in Oxford scores (0-5), bigger number means stronger contraction.
Time frame: Measured before starting the program, after first set of training (6 months from beginning) and after second set of training (12 months from beginning)
changes in POP-Q scales (especially in gh - genital hiatus, pb - perineal body, measured by centimeters, bigger number in gh means wider genital hiatus -worse outcome; smaller number in pb means thin perineal body - worse outcome)
Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning).
Quality of Life (QoL) and clinical outcome questionnaires: * ICIQ-UI SF (International Consultation on Incontinence Questionnaire Short Form); scores 1-21, higher the number - worse outcome
Time frame: Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning
observation (compensatory muscles: abdominal, thighs, glutes movements during the contraction)
Time frame: Measured before training, immediately after first set of training, 6 months from the beginning, before starting second set of training and immediately after second set of training, about 12 months from the beginning
Contraction measured with Myomed biofeedback device (manometry kPha)
Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning).
P-QoL (Prolapse Quality-of-Life Questionnaire) measures the impact of pelvic organ prolapse (POP) on a patient's life across eight domains, with total scores ranging from 0 (best) to 100 (worst). High scores indicate poor quality of life, while lower scores (often <40 or <20) indicate higher QOL and improvement after intervention
Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)
PISQ-IR (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA revised) evaluates female sexual function (FSF) in women with pelvic floor disorders (PFD), using a 2.68 summary score cutoff for sexually active (SA) women to identify sexual dysfunction (values >2.68 indicate no dysfunction). The survey separates patients into SA and not sexually active (NSA) groups.
SA Scale: Higher scores indicate better sexual function. A mean score (>2.68) suggests no dysfunction, with (90%) sensitivity and (73%) specificity.NSA Scale: Higher scores indicate a greater negative impact of pelvic floor disorders on sexual inactivity.
Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)
FSFI (Female Sexual Function Index) is a 19-item validated questionnaire assessing female sexual function over the past month, with total scores ranging from 2.0 to 36.0. A total score of ≤26.55 is the standard cutoff indicating a potential risk for Female Sexual Dysfunction (FSD). Higher scores indicate better, more robust sexual functioning
Time frame: Questionnaires will be given at the beginning (excluding sexual function related questionnaires, due to short time after delivery), after first set of training (6 months from the beginning), after second set of training (12 months from the beginning)
MOS-SF36 (Medical Outcomes Study Short Form-36). s a 36-item, patient-reported survey measuring health-related quality of life across eight dimensions. Scores range from 0 to 100 for each subscale, with higher scores indicating better health functioning or fewer limitations. The survey evaluates physical, mental, and social health domains
Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum
Age in years Advanced age is a risk factor for PFD
Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum
BMI (kg/m^2) Higher BMI is a risk factor for PFD
Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum
Number of births (after 22 gestational weeks) Higher number of births is a risk factor for PFD
Time frame: Asked and documented at first postpartum visit, 6-8 weeks postpartum
Mode of delivery: natural, vacuum, forceps, c - section Vacuum or forceps assisted delivery is related to higher PFD rates compared to c - section or natural
Contact information is provided by the study sponsor or research team.
Vilnius University
Other
Prevention of Female Pelvic Floor Dysfunction Rehabilitation Postpartum.
Acronym: DDDPREV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06677541
Pelvic Floor Dysfunction, Sexual Dysfunction Female
Albany, New York, United States
View Trial DetailsNCT06848634
Behavior, Chronic Pelvic Pain
View Trial DetailsNCT04036578
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
View Trial DetailsNCT07727837
Defecation Disorders, Pelvic Floor Dysfunction
Izmir, Bornova, Turkey (Türkiye)
View Trial Details